These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 12558459

  • 21. [Hypolipidemic treatment under special conditions: posttransplant and/or immunosuppressive therapy].
    Izar MC.
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():50-7. PubMed ID: 16400400
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients.
    Taylor PJ, Kubler PA, Lynch SV, Allen J, Butler M, Pillans PI.
    Ann Pharmacother; 2004 Feb; 38(2):205-8. PubMed ID: 14742751
    [Abstract] [Full Text] [Related]

  • 29. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.
    Dunn CJ, Wagstaff AJ, Perry CM, Plosker GL, Goa KL.
    Drugs; 2001 Feb; 61(13):1957-2016. PubMed ID: 11708766
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.
    Fichtenbaum CJ, Gerber JG.
    Clin Pharmacokinet; 2002 Feb; 41(14):1195-211. PubMed ID: 12405866
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Does differing metabolism by cytochrome p450 have clinical importance?
    Davidson MH.
    Curr Atheroscler Rep; 2000 Jan; 2(1):14-9. PubMed ID: 11122720
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Management of protease inhibitor-associated hyperlipidemia.
    Penzak SR, Chuck SK.
    Am J Cardiovasc Drugs; 2002 Jan; 2(2):91-106. PubMed ID: 14727985
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Interaction of cyclosporin with CSE inhibitors].
    Martini B.
    Med Monatsschr Pharm; 2006 Oct; 29(10):379. PubMed ID: 17058898
    [No Abstract] [Full Text] [Related]

  • 39. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.
    Yee HS, Fong NT.
    Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.